Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Pittsburgh
Collaborators
NCT07146633 · Posttraumatic Stress Disorder (PTSD), Substance Use Disorders
NCT06413979 · Internalizing Disorders, Substance Use Disorders
NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more
NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more
NCT05492825 · Substance Use Disorders, Chronic Pain, and more
Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions